Edgewell Personal Care Company (EPC) Cash Flow Statement
Where EPC’s cash came from and went, FY2025
September 30, 2025 · U.S. dollars- Cash from operations
- $118.4M −48.7% vs FY2024
- Capital expenditures
- $77.0M 3.5% of revenue
- Free cash flow
- $41.4M 1.9% margin
- Returned to shareholders
- $119.5M 289% of free cash flow
- Change in cash
- $16.6M cash at year-end $225.7M
Drawn to scale: where the cash came from and how it was used. Hover for values.
EPC operating cash flow, capex and free cash flow
EPC cash flow trends, FY2016–FY2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Operating cash flow | $176.4MFY2016 | $118.4MFY2025 | −4.3%/yr | |
| Capital expenditures | $69.5MFY2016 | $77.0MFY2025 | +1.1%/yr | |
| Free cash flow | $106.9MFY2016 | $41.4MFY2025 | −10.0%/yr | |
| Free cash flow margin | 4.5%FY2016 | 1.9%FY2025 | −2.7 pts | |
| Operating cash flow / net income | 0.99FY2016 | 4.66FY2025 | +3.67 | |
| Stock-based compensation | $25.6MFY2016 | $24.5MFY2025 | −0.5%/yr | |
| Dividends paid | $0FY2016 | $29.3MFY2025 | — | |
| Share buybacks (net) | $196.6MFY2016 | $90.2MFY2025 | −8.3%/yr | |
| Capex / revenue | 2.9%FY2016 | 3.5%FY2025 | +0.5 pts |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
EPC cash flow by activity
EPC net income vs operating cash flow
Operating cash flow above net income usually means earnings are backed by cash (depreciation and stock-based pay are non-cash expenses).
EPC cash flow statement
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||
| Net income | $25.4M | $98.6M | $112.9M | $98.6M | $117.0M | $67.6M | −$352.9M | $103.3M | $5.7M | $178.7M |
| Depreciation & amortization | $88.8M | $88.0M | $91.4M | $89.9M | $87.1M | $88.8M | $93.8M | $97.6M | $94.4M | $92.6M |
| Stock-based compensation | $24.5M | $26.5M | $27.5M | $23.8M | $27.3M | $19.2M | $17.8M | $17.0M | $22.2M | $25.6M |
| Change in working capital | −$25.8M | $47.6M | $6.8M | −$81.0M | −$26.9M | $43.2M | −$47.5M | $1.1M | −$20.7M | −$18.5M |
| Other non-cash items | $5.5M | −$29.7M | −$22.5M | −$29.3M | $24.5M | $13.8M | $479.4M | $45.7M | $194.6M | −$102.0M |
| Cash from operating activities | $118.4M | $231.0M | $216.1M | $102.0M | $229.0M | $232.6M | $190.6M | $264.7M | $296.2M | $176.4M |
| Investing activities | ||||||||||
| Capital expenditures | −$77.0M | −$56.5M | −$49.5M | −$56.4M | −$56.8M | −$47.7M | −$58.0M | −$62.0M | −$69.0M | −$69.5M |
| Investments (net) | −$72.9M | −$62.4M | −$50.5M | −$355.4M | −$48.7M | −$9.5M | −$45.5M | −$128.5M | −$84.6M | −$69.5M |
| Acquisitions & other investing | $77.0M | $56.5M | $49.5M | $56.4M | $56.8M | −$139.2M | $58.0M | $62.0M | $69.0M | $69.5M |
| Cash from investing activities | −$72.9M | −$62.4M | −$50.5M | −$355.4M | −$48.7M | −$196.4M | −$45.5M | −$128.5M | −$84.6M | −$69.5M |
| Financing activities | ||||||||||
| Dividends paid | −$29.3M | −$30.7M | −$31.5M | −$32.6M | −$25.6M | −$2.0M | −$25.6M | −$25.6M | $0 | $0 |
| Share repurchases & issuance (net) | −$90.2M | −$58.5M | −$75.2M | −$125.3M | −$9.2M | −$2.0M | −$3.0M | −$124.4M | −$165.4M | −$196.6M |
| Net borrowing (repayment) | $111.5M | −$83.8M | −$33.0M | $151.1M | $4.2M | $24.3M | −$69.2M | $550.0M | $271.0M | $756.3M |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $750.0M | $0 | $0 | $0 | $0 |
| Other financing | −$22.0M | −$6.4M | −$6.8M | −$10.8M | −$34.8M | −$789.0M | $34.0M | −$775.2M | −$566.2M | −$642.7M |
| Cash from financing activities | −$30.0M | −$179.4M | −$146.5M | −$17.6M | −$65.4M | −$18.7M | −$63.8M | −$375.2M | −$460.6M | −$83.0M |
| Summary | ||||||||||
| Net change in cash | $16.6M | −$7.3M | $27.7M | −$290.5M | $114.5M | $23.1M | $75.2M | −$236.5M | −$236.0M | $26.8M |
| Cash at end of period | $225.7M | $209.1M | $216.4M | $188.7M | $479.2M | $364.7M | $341.6M | $266.4M | $502.9M | $738.9M |
| Free cash flow | $41.4M | $174.5M | $166.6M | $45.6M | $172.2M | $184.9M | $132.6M | $202.7M | $227.2M | $106.9M |
| Free cash flow margin | 1.9% | 7.7% | 7.4% | 2.1% | 8.2% | 9.5% | 6.2% | 9.1% | 9.9% | 4.5% |
| Capex / revenue | 3.5% | 2.5% | 2.2% | 2.6% | 2.7% | 2.4% | 2.7% | 2.8% | 3.0% | 2.9% |
| Operating cash flow / net income | 4.66 | 2.34 | 1.91 | 1.03 | 1.96 | 3.44 | — | 2.56 | 51.96 | 0.99 |
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 | Jun '24 | Mar '24 | Dec '23 | Sep '23 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating activities | ||||||||||||
| Net income | −$22.8M | −$10.6M | −$29.2M | −$30.6M | $29.1M | $29.0M | −$2.1M | $8.8M | $49.0M | $36.0M | $4.8M | $29.5M |
| Depreciation & amortization | $18.6M | $19.1M | $21.3M | $23.2M | $22.1M | $21.8M | $21.7M | $21.4M | $21.7M | $22.4M | $22.5M | $23.3M |
| Stock-based compensation | $5.7M | $5.6M | $3.4M | $5.7M | $6.4M | $6.3M | $6.1M | $6.1M | $7.1M | $6.3M | $7.0M | $7.7M |
| Change in working capital | $83.9M | $82.4M | −$137.5M | $56.9M | $62.1M | $200,000 | −$145.0M | $56.1M | $27.6M | $70.0M | −$106.1M | −$1.0M |
| Other non-cash items | $33.3M | −$42.2M | $16.1M | $18.9M | −$4.9M | −$12.2M | $3.7M | −$18.7M | −$4.2M | −$5.7M | −$1.1M | −$11.7M |
| Cash from operating activities | $118.7M | $54.3M | −$125.9M | $74.1M | $114.8M | $45.1M | −$115.6M | $73.7M | $101.2M | $129.0M | −$72.9M | $47.8M |
| Investing activities | ||||||||||||
| Capital expenditures | −$15.6M | −$14.0M | −$11.6M | −$27.6M | −$15.5M | −$17.1M | −$16.8M | −$25.9M | −$12.6M | −$11.5M | −$6.5M | −$18.4M |
| Investments (net) | — | — | — | −$27.6M | −$12.3M | −$17.3M | −$15.7M | −$25.5M | −$17.2M | −$13.7M | −$6.0M | −$18.9M |
| Acquisitions & other investing | $1.5M | $339.0M | $1.7M | $27.6M | $15.5M | $17.1M | $16.8M | $25.9M | $12.6M | $11.5M | $6.5M | −$13.2M |
| Cash from investing activities | −$14.1M | $325.0M | −$9.9M | −$27.6M | −$12.3M | −$17.3M | −$15.7M | −$25.5M | −$17.2M | −$13.7M | −$6.0M | −$50.5M |
| Financing activities | ||||||||||||
| Dividends paid | −$7.0M | −$7.1M | −$7.4M | −$6.9M | −$7.2M | −$7.3M | −$7.9M | −$7.4M | −$7.5M | −$8.2M | −$7.6M | −$7.7M |
| Share repurchases & issuance (net) | $2.8M | −$15.8M | −$2.8M | −$100,000 | −$24.5M | −$35.4M | −$30.3M | −$18.3M | −$9.9M | −$15.3M | −$15.0M | −$30.0M |
| Net borrowing (repayment) | −$1.5M | −$274.8M | $139.4M | $16.3M | −$65.3M | −$8.2M | $168.7M | −$13.7M | — | — | — | $31.9M |
| Shares issued | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other financing | −$1.6M | −$3.1M | $4.2M | −$28.4M | $13.6M | $13.5M | −$20.6M | −$700,000 | −$62.5M | −$105.7M | $92.4M | −$8.4M |
| Cash from financing activities | −$7.3M | −$300.8M | $133.4M | −$19.1M | −$83.4M | −$37.4M | $109.9M | −$40.1M | −$79.9M | −$129.2M | $69.8M | −$14.2M |
| Summary | ||||||||||||
| Net change in cash | $97.4M | $76.4M | −$2.4M | $26.1M | $29.5M | −$5.4M | −$33.6M | $13.0M | −$100,000 | −$18.0M | −$2.2M | $9.0M |
| Cash at end of period | $397.1M | $299.7M | $223.3M | $225.7M | $199.6M | $170.1M | $175.5M | $209.1M | $196.1M | $196.2M | $214.2M | $216.4M |
| Free cash flow | $103.1M | $40.3M | −$137.5M | $46.5M | $99.3M | $28.0M | −$132.4M | $47.8M | $88.6M | $117.5M | −$79.4M | $29.4M |
| Free cash flow margin | 18.1% | 7.8% | −32.5% | 8.7% | 15.8% | 4.8% | −27.7% | 9.2% | 13.7% | 19.6% | −16.2% | 5.5% |
| Capex / revenue | 2.7% | 2.7% | 2.7% | 5.1% | 2.5% | 2.9% | 3.5% | 5.0% | 1.9% | 1.9% | 1.3% | 3.4% |
| Operating cash flow / net income | — | — | — | — | 3.95 | 1.56 | — | 8.38 | 2.07 | 3.58 | −15.19 | 1.62 |
Negative numbers are cash paid out. Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported; data from EODHD.
EPC cash generation
In fiscal 2025 (ended September 30, 2025), Edgewell Personal Care generated $118.4 million of cash from operations (down 48.7%) and spent $77.0 million on capital expenditures, leaving free cash flow of $41.4 million, 1.9% of revenue. It returned $119.5 million to shareholders through dividends ($29.3 million) and net share buybacks ($90.2 million). Cash and equivalents rose by $16.6 million over the year.
Related: EPC income statement, EPC balance sheet, EPC dividend history. See the EPC stock overview for the latest quote and news.
EPC cash flow FAQ
What is Edgewell Personal Care's free cash flow?
Edgewell Personal Care's free cash flow was $41.4 million in fiscal 2025: $118.4 million of operating cash flow minus $77.0 million of capital expenditures It was $174.5 million a year earlier..
How much cash does Edgewell Personal Care generate from operations?
Edgewell Personal Care generated $118.4 million of cash from operating activities in fiscal 2025, 4.66 times its net income of $25.4 million.
How much does Edgewell Personal Care spend on capital expenditures?
Edgewell Personal Care spent $77.0 million on capital expenditures in fiscal 2025, 3.5% of revenue, compared with $56.5 million the year before.
How much stock does Edgewell Personal Care buy back?
Edgewell Personal Care spent $90.2 million on net share repurchases in fiscal 2025.
How much does Edgewell Personal Care pay in dividends?
Edgewell Personal Care paid $29.3 million in dividends in fiscal 2025, 70.8% of free cash flow.